Status:

UNKNOWN

The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics

Lead Sponsor:

RenJi Hospital

Conditions:

Obesity

Type 2 Diabetes

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This is a prospective, randomized, open-label, active drug controlled clinical trial that aims to compare the effects of henagliflozin or metformin on myocardial tissue level characteristics in type 2...

Detailed Description

MRI scanning will be assessed at baseline and at the end of the treatment period in order to to assess the cardiac morphology, cardiac function, and myocardial tissue characteristics. The cardiac MRI ...

Eligibility Criteria

Inclusion

  • Individuals with type 2 diabetes newly diagnosed based on the WHO (1999) criteria;
  • Hemoglobin A1c levels \>=7.0% and \<=8.0%;
  • Females or males ≥18 years up to 75 years of age.

Exclusion

  • Females or males \<18 years.
  • Clinical diagnosis of type 1 diabetes and other types of diabetes.
  • Blood pressure at screening that would require a change in blood pressure treatment over the study period.
  • History of stroke or other clinically significant cerebrovascular disease.
  • Any of the following cardiovascular diseases:
  • Atrial fibrillation, or other unstable or severe arrhythmia affecting heart function
  • Unstable heart failure or any heart failure with NYHA class III and IV
  • Significant valvular disease
  • Significant peripheral artery disease
  • Active malignancy requiring treatment at the time of visit 0.
  • Patients with severe hepatic impairment.
  • Unstable or rapidly progressing renal disease.
  • Ongoing treatment with loop diuretics.
  • Estimated Glomerular Filtration Rate (eGFR) \<45 mL/min/1.73 m2.
  • Women who has a positive pregnancy test at enrolment or randomization, or are breastfeeding.

Key Trial Info

Start Date :

October 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT06059287

Start Date

October 1 2023

End Date

December 31 2025

Last Update

September 28 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.